Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening-Reference-Cited by-同舟云学术

Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening

Published:2017-11-14 Issue:5 Volume:110 Page:501-508
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Schiffman Mark¹,Kinney Walter K²,Cheung Li C¹,Gage Julia C¹,Fetterman Barbara²,Poitras Nancy E²,Lorey Thomas S²,Wentzensen Nicolas¹,Befano Brian³,Schussler John³,Katki Hormuzd A¹,Castle Philip E⁴

Affiliation:

1. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD

2. Regional Laboratory, The Permanente Medical Group, Oakland, CA

3. Information Management Services, Calverton, MD

4. Albert Einstein College of Medicine, Bronx, NY

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/110/5/501/24797249/djx225.pdf

Reference44 articles.

1. Human papillomavirus and cervical cancer;Schiffman;Lancet.,2007

2. Overview of the European and North American studies on HPV testing in primary cervical cancer screening;Cuzick;Int J Cancer.,2006

3. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer;Mayrand;N Engl J Med.,2007

4. Human papillomavirus and Papanicolaou tests to screen for cervical cancer;Naucler;N Engl J Med.,2007

5. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: Final results of the POBASCAM randomised controlled trial;Rijkaart;Lancet Oncol.,2012

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the landscape of HPV-associated cancers: From epidemiology to prevention;Pathology - Research and Practice;2024-11

2. Something old, something new: Cervical cytopathology in the new era;Human Pathology Reports;2024-09

3. Primary human papillomavirus testing vs cotesting: clinical outcomes in populations with different disease prevalence;JNCI: Journal of the National Cancer Institute;2024-06-03

4. Effectiveness of high-risk human papillomavirus genotyping for cervical cancer screening. A multicentre screening cohort study in rural China;Anales del Sistema Sanitario de Navarra;2024-05-31

5. How do young women approaching screening age interpret the NHS cervical screening leaflet? A mixed methods study of identifying interpretation difficulties, barriers, facilitators, and leaflet interpretation, engagement and future screening behaviour;Health Psychology and Behavioral Medicine;2024-05-30